{
  "nctId": "NCT02328768",
  "briefTitle": "Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children",
  "officialTitle": "Compassionate Use of an Intravenous Fish Oil Lipid Emulsion (Omegaven®) for the Treatment of Intestinal Failure Associated Liver Disease in Children",
  "protocolDocument": {
    "nctId": "NCT02328768",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2017-01-03",
    "uploadDate": "2022-12-02T15:44",
    "size": 385942,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02328768/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "EXPANDED_ACCESS",
  "enrollmentInfo": {},
  "timeline": {
    "firstSubmitDate": "2014-12-19",
    "firstPostDate": "2014-12-31"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Parenteral nutrition (PN) dependent (unable to meet nutritional needs solely by enteral nutrition) and expected to require PN for at least another 30 days.\n* Parenteral nutrition associated liver disease (PNALD) as defined as a direct bilirubin ≥ 2mg/dL or by histology and/or currently on Omegaven through another protocol.\n* Other causes of liver disease have been excluded. A liver biopsy is not necessary for treatment.\n* Exhaustion of standard therapies to prevent the progression of the liver disease including surgical treatment, cyclic PN, avoiding overfeeding, reduction/removal of copper and manganese form PN, advancement of enteral feeding, and the use of ursodiol.\n\nExclusion Criteria:\n\n* Pregnancy\n* Other causes of liver disease\n* Enrollment in any other clinical trial involving an investigational agent (unless approved by the designated physicians on the multidisciplinary team)\n* The parent/guardian or subject is unwilling to provide consent and assent",
    "healthyVolunteers": false,
    "sex": "ALL",
    "maximumAge": "18 Years",
    "stdAges": [
      "CHILD",
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 0,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 0
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 19,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:30:10.508Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}